Introduction
============

Nasopharyngeal carcinoma (NPC) is considered one of the rarer cancer forms globally, with an estimated 84,400 incident cases and 51,600 deaths in 2008, representing the 24th most frequently diagnosed cancer form globally and the 22nd most frequently diagnosed cancer within the developing countries.[@b1-ott-8-2479] However, there is an obvious difference in the distribution of NPC incidence, and the highest incidence rate is in the People's Republic of China and Southeast Asian region.[@b2-ott-8-2479],[@b3-ott-8-2479] NPC ranked eleventh among all malignancies in the People's Republic of China in 2008, with an incidence rate of 2.8/100,000 person-years in men and 1.9/100,000 person-years in women.[@b3-ott-8-2479] The exact pathogenesis of NPC has not yet been understood up till now. Apart from Epstein--Barr virus infection and exposures to environmental carcinogens, genetic susceptibility seems to be a risk factor playing a crucial role in the development of NPC.[@b4-ott-8-2479]

In recent years, several common, low-penetrant genes have been identified as potential NPC susceptibility genes. An important one is glutathione *S*-transferase (GST), which is one of the detoxification enzyme systems and plays an important role in inactivating endogenous and exogenous toxic products under oxidative stress. The GST isoenzymes have been reported to express classes mu, theta, and pi in human lens tissue.[@b5-ott-8-2479] Located on chromosome 1 at 1p13.3, the *GSTM1* plays an important role in the xenobiotics' detoxification. The most common genotype of *GSTM1* gene is homozygous deletion (null genotype), which has been suggested to be associated with the loss of enzyme activity, increased vulnerability to cytogenetic damage, and results in the increased susceptibility to cancers, including NPC.[@b6-ott-8-2479],[@b7-ott-8-2479] Meta-analyses of related studies in other ethnic groups have also produced conflicting results due to several factors such as environmental factors, family history, and different genetic backgrounds.[@b8-ott-8-2479]--[@b11-ott-8-2479] Therefore, we conducted an updated meta-analysis to more precisely define the effect of *GSTM1* polymorphism on the risk of NPC in the Chinese population only, in an attempt to investigate race-specific effects.

Materials and methods
=====================

The authors advise that the Ethics Committee of Huazhong University of Science and Technology did not require that this study have ethics approval because it is only a meta-analysis rather than an experiment or case-control study.

Search strategy and study selection
-----------------------------------

We conducted a systematic literature search for published articles regarding the association of *GSTM1* polymorphism and NPC risk. The studies were searched in PubMed, Springer Link, Ovid, Chinese Wanfang Data Knowledge Service Platform, Chinese National Knowledge Infrastructure (CNKI), and Chinese Biology Medicine (CBM) up to January 5, 2015, using the combination of following terms: 1) glutathione-*S*-transferase M1, GSTM, GSTM1; 2) nasopharyngeal cancer, nasopharyngeal carcinoma, or NPC; 3) polymorphism or variant or variation; and 4) Chinese or China or Taiwan. The search was performed without any restrictions on language and focused on studies conducted on humans. In addition to the electronic database search, all reference lists of retrieved articles were manually reviewed to identify additional articles. In our meta-analysis, studies were included if the following criteria were met: 1) if they were case-control or cohort studies describing the association of *GSTM1* deletion polymorphism and NPC, 2) if all patients with the diagnosis of NPC were confirmed as having the disease by pathological or histological examinations, 3) if there was a clear description of *GSTM1* polymorphism in NPC patients and controls, and 4) if all participants were Chinese. The reasons for exclusion of studies were: 1) duplicate publications, 2) incomplete data, 3) no control, 4) meta-analyses, letters, reviews, or editorial articles.

Data extraction
---------------

Two investigators independently extracted information from all eligible publications according to the inclusion criteria listed in the earlier section. Disagreements were settled out by discussion among all reviewers. The title and abstract of all potentially relevant articles were screened to determine their relevance. Full articles were also scrutinized if the title and abstract were ambiguous. We extracted standardized data sets from studies of *GSTM1* polymorphism and NPC. The following information was sought from each publication: the first author, publication year, source of controls, geographic area, sample size, and the number of subjects with two *GSTM1* genotypes. In this meta-analysis, the quality assessment of each individual study was conducted according to the nine-star Newcastle--Ottawa Scale.[@b12-ott-8-2479]

Statistical analysis
--------------------

The strength of the association between *GSTM1* null allele and risk of NPC in Chinese was measured by crude odds ratios (ORs) with 95% confidence intervals (95% CIs), and the significance of the pooled OR was determined by the *Z* test. Given that there was distribution of null/present heterozygote in only one study selected,[@b13-ott-8-2479] the Hardy--Weinberg equilibrium (HWE) test could not be conducted. Cochran's *Q*-statistic was used to assess between-study heterogeneity, and a significant *Q*-statistic (*P*\<0.10) indicated heterogeneity across studies. If there was heterogeneity, then the random-effects model was chosen to pool the OR with 95% CI, otherwise the fixed-effects model was used. Sensitivity analysis was conducted to verify stability of the meta-analysis using both models (the fixed-effects model and random-effects model). Publication bias was investigated with the funnel plot, in which the standard error (SE) of log OR of each study was plotted against its OR. Funnel-plot asymmetry was further assessed by the method of Begg's and Egger's tests. Moreover, subgroup analyses were performed to test whether the effect size varied by the smoking status and the source of control population. All statistical analyses were conducted using Stata version 10.0 (Stata Corp, College Station, TX, USA). A two-sided *P*\<0.05 was considered statistically significant.

Results
=======

Description of included studies
-------------------------------

A total of 22 articles that examined the association between *GSTM1* polymorphisms and risk of NPC were identified. After screening the titles and abstracts of these articles, nine were excluded. Of the remaining 13 potentially relevant articles, three were excluded because they concerned subjects included in an expanded series and one in North China[@b14-ott-8-2479] was also excluded due to the possible bias from geographic areas. The flowchart of study selection is shown in [Figure 1](#f1-ott-8-2479){ref-type="fig"}. Finally, nine case-control studies[@b13-ott-8-2479],[@b15-ott-8-2479]--[@b22-ott-8-2479] including 1,291 NPC cases and 2,135 controls were involved in this meta-analysis, which evaluated the relationship between *GSTM1* polymorphism and NPC risk. The source of controls was mainly based on a healthy population. The geographic areas were all in South China. The characteristics of the included studies are summarized in [Table 1](#t1-ott-8-2479){ref-type="table"}.

Quantitative data synthesis
---------------------------

### Overall analysis

There was no evidence of between-study heterogeneity in all included studies (*χ*~2~=11.58, *P*=0.171). Therefore, the fixed-effects model was used in overall analysis. The results showed that the pooled OR with 95% CI for NPC in South China with null *GSTM1* was 1.47 (1.27--1.70, *P*=0.000) ([Figure 2A](#f2-ott-8-2479){ref-type="fig"}). In addition, the finding from cumulative meta-analysis showed that there was a trend of more obvious association between the *GSTM1* null genotype and risk of NPC in South China based on the data accumulated by publication year ([Figure 2B](#f2-ott-8-2479){ref-type="fig"}).

### Subgroup analysis

In the subgroup analysis based on smoking status, the results showed that the *GSTM1* polymorphism was significantly related to NPC risk among smokers (OR =3.16, 95% CI: 1.76--5.67, *P*=000), but not among nonsmokers (OR =1.01, 95% CI: 0.56--1.82, *P*=0.982) ([Table 2](#t2-ott-8-2479){ref-type="table"}). In addition, we also performed stratified analysis based on the source of control: it revealed the significant results in population-based studies (OR =1.40, 95% CI: 1.19--1.64, *P*=000) ([Table 2](#t2-ott-8-2479){ref-type="table"}).

### Sensitivity analysis and bias diagnosis

In order to compare the difference and evaluate the sensitivity of the meta-analyses, we used both models (the fixed-effects model and the random-effects model) to evaluate the stability of the meta-analysis. All results were not materially altered, except the subgroup analysis for nonsmokers ([Table 2](#t2-ott-8-2479){ref-type="table"}). Hence, results of the sensitivity analysis suggest that the data in this meta-analysis are relatively stable and credible. The Begg's funnel plot and Egger's test were performed to assess the publication bias of literatures. The shape of the funnel plots did reveal obvious asymmetry ([Figure 3A](#f3-ott-8-2479){ref-type="fig"}). Then, the Begg's and Egger's tests were used to provide statistical evidence of funnel-plot symmetry. The Begg's and Egger's tests indicated that there was obvious publication bias in overall analyses ([Figure 3B](#f3-ott-8-2479){ref-type="fig"}, *Z*=2.29, *P*=0.022; *t*=3.23, *P*=0.014).

Discussion
==========

This meta-analysis aimed to systematically summarize the epidemiological evidence for the association between *GSTM1* null genotype and risk of NPC in Chinese. Nine case-control studies with 1,291 NPC cases and 2,135 controls were finally included in the meta-analysis. The meta-analysis of a total of nine studies showed that *GSTM1* null genotype was significantly associated with an increased risk of NPC in South China ([Figure 2A](#f2-ott-8-2479){ref-type="fig"}). The findings from the cumulative meta-analysis showed that there was a trend of more obvious association between *GSTM1* null genotype and risk of NPC in Chinese from South China based on data accumulated by publication year ([Figure 2B](#f2-ott-8-2479){ref-type="fig"}). Therefore, *GSTM1* null genotype is significantly associated with an increased risk of NPC in South China. The findings from this meta-analysis provide new and strong epidemiological evidence for the association between *GSTM1* null genotype and risk of NPC in Chinese. To date, four meta-analyses have been published, assessing the association between *GSTM1* polymorphism and NPC risk, but the existing evidence was still weak due to limited sample size in Chinese populations, ethnic difference, or disagreements among the published studies.[@b8-ott-8-2479]--[@b11-ott-8-2479] To our knowledge, our study represented the first meta-analysis with a large sample size, studying the interaction of *GSTM1* variant with NPC in the Chinese population. Therefore, the present meta-analysis of all available case-control studies was conducted to shed some light on those inconsistent results.

Furthermore, the interaction between *GSTM1* null genotype and tobacco smoking for the risk of NPC has been evaluated by several studies with inconsistent results, possibly because of small sample size.[@b8-ott-8-2479] Thus, we performed another analysis stratified by smoking to ascertain the interaction by pooling all available studies. We found that the *GSTM1* null genotype significantly increased the risk of NPC in smokers. In addition, results of the sensitivity analysis suggest that the data are stable and credible. We concluded that the association between *GSTM1* null genotype and NPC risk was strongest in individuals with exposure to smoking. Moreover, the association between the extent of smoke exposure and NPC risk was not clear; further studies with larger sample size are needed to provide insights into the interaction association. When we performed the subgroup analyses comparing with control groups, significant association with susceptibility for the development of NPC was found in population-based studies. There might be some explanations for the significant association. First, gene--gene or gene--environmental interactions might play an important role in susceptibility to NPC. In addition, decades of epidemiological studies have shown that NPC has unique prevalence features, including regional, racial, and familial aggregation.[@b3-ott-8-2479]

The pathways of carcinogen metabolism are complex, mediated by the activities of multiple genes. The effect of any single gene might have a limited impact on NPC risk than have so far been anticipated. NPC has some known major environmental determinants other than Epstein--Barr virus infection, and large studies with detailed exposure information are needed to evaluate reliably any moderate genetic effects. Otherwise, some limitations should be acknowledged. First, all studies included in this meta-analysis were in South China, because of the limited data in North China. Some inevitable biases may exist. Second, our results were based on unadjusted estimates. More precise analyses can be conducted if individual data were available, which would allow for the adjustment by other covariates including age, sex, race, and other factors. Finally, because the papers searched in our study were limited to those openly published, it is possible that some related unpublished studies that may meet the inclusion criteria were missed. Hence, a publication bias was evident in Begg's and Egger's tests in relation to *GSTM1* null genotype, which may interfere with the interpretation of the results. However, a careful search of published studies and subgroup analyses were conducted to minimize this.

Conclusion
==========

In conclusion, our meta-analysis supports that *GSTM1* null genotype might contribute to individual susceptibility to NPC in South China. In the future, more studies on gene--gene and gene--environment interactions are required. Such studies taking these factors into account may eventually lead to a better understanding of the effect of *GSTM1* null genotype in the development of NPC.
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![Flowchart of the literature search.](ott-8-2479Fig1){#f1-ott-8-2479}

![The forest plots of all selected studies on the association between *GSTM1* polymorphism and NPC risk in South China.\
**Notes:** (**A**) Meta-analysis; (**B**) cumulative meta-analysis. Weights are from fixed-effects analysis.\
**Abbreviations:** CI, confidence interval; NPC, nasopharyngeal carcinoma; OR, odds ratio.](ott-8-2479Fig2){#f2-ott-8-2479}

![Publication bias assessment of *GSTM1* polymorphism and NPC risk in Chinese.\
**Notes:** (**A**) Begg's funnel plot, (**B**) Egger's test.\
**Abbreviations:** SE, standard error; NPC, nasopharyngeal carcinoma; OR, odds ratio.](ott-8-2479Fig3){#f3-ott-8-2479}

###### 

Characteristics of studies included in the meta-analysis

  References                     Source of controls   Area        Case number   Control number   Case   Control   Quality score   Case (smoking)   Control (smoking)                                                                                                                                                   
  ------------------------------ -------------------- ----------- ------------- ---------------- ------ --------- --------------- ---------------- ------------------- ----------------------------------------------- ----------------------------------------------- ----------------------------------------------- -----------------------------------------------
  Da et al[@b15-ott-8-2479]      PB                   Hunan       80            80               48     32        36              44               7                   36                                              16                                              16                                              20
  Cheng et al[@b16-ott-8-2479]   PB                   Taiwan      314           337              173    141       169             168              8                   NA[\*](#tfn1-ott-8-2479){ref-type="table-fn"}   NA[\*](#tfn1-ott-8-2479){ref-type="table-fn"}   NA[\*](#tfn1-ott-8-2479){ref-type="table-fn"}   NA[\*](#tfn1-ott-8-2479){ref-type="table-fn"}
  Deng et al[@b17-ott-8-2479]    PB                   Guangxi     127           207              78     49        95              112              7                   NA[\*](#tfn1-ott-8-2479){ref-type="table-fn"}   NA[\*](#tfn1-ott-8-2479){ref-type="table-fn"}   NA[\*](#tfn1-ott-8-2479){ref-type="table-fn"}   NA[\*](#tfn1-ott-8-2479){ref-type="table-fn"}
  Liao et al[@b18-ott-8-2479]    PB                   Guangxi     80            72               50     30        32              40               8                   NA[\*](#tfn1-ott-8-2479){ref-type="table-fn"}   NA[\*](#tfn1-ott-8-2479){ref-type="table-fn"}   NA[\*](#tfn1-ott-8-2479){ref-type="table-fn"}   NA[\*](#tfn1-ott-8-2479){ref-type="table-fn"}
  Guo et al[@b19-ott-8-2479]     PB                   Guangxi     341           590              204    137       328             262              8                   NA[\*](#tfn1-ott-8-2479){ref-type="table-fn"}   NA[\*](#tfn1-ott-8-2479){ref-type="table-fn"}   NA[\*](#tfn1-ott-8-2479){ref-type="table-fn"}   NA[\*](#tfn1-ott-8-2479){ref-type="table-fn"}
  He et al[@b13-ott-8-2479]      PB                   Guangdong   100           100              45     55        42              58               8                   NA[\*](#tfn1-ott-8-2479){ref-type="table-fn"}   NA[\*](#tfn1-ott-8-2479){ref-type="table-fn"}   NA[\*](#tfn1-ott-8-2479){ref-type="table-fn"}   NA[\*](#tfn1-ott-8-2479){ref-type="table-fn"}
  Wei et al[@b20-ott-8-2479]     HB                   Guangxi     126           641              78     48        305             336              8                   NA[\*](#tfn1-ott-8-2479){ref-type="table-fn"}   NA[\*](#tfn1-ott-8-2479){ref-type="table-fn"}   NA[\*](#tfn1-ott-8-2479){ref-type="table-fn"}   NA[\*](#tfn1-ott-8-2479){ref-type="table-fn"}
  Zhang[@b21-ott-8-2479]         PB + HB              Yunnan      45            30               27     18        11              19               7                   12                                              8                                               3                                               10
  Yang et al[@b22-ott-8-2479]    PB                   Hunan       78            78               51     27        35              43               6                   36                                              15                                              15                                              19

**Note:**

There is no gene data for smoking in these articles.

**Abbreviations:** HB, hospital-based; PB, population-based; NA, not available.

###### 

Main results in the total and subgroup analysis

  ----------------------------------------------------------------------------------------------------
  Subgroups           Study\   Random-effects model    Fixed-effects model     Heterogeneity   
                      (n)                                                                      
  ------------------- -------- ----------------------- ----------------------- --------------- -------
  Total analysis      9        **1.54 (1.28--1.86)**   **1.47 (1.27--1.70)**   11.58           0.171

  Source of control                                                                            

   Population-based   7        **1.47 (1.19--1.80)**   **1.40 (1.19--1.64)**   8.86            0.182

  Smoking                                                                                      

   Smokers            3        **3.15 (1.75--5.66)**   **3.16 (1.76--5.67)**   0.40            0.818

   Nonsmokers         3        1.01 (0.55--1.83)       1.01 (0.56--1.82)       0.88            0.645
  ----------------------------------------------------------------------------------------------------

**Note:** Data shown in bold represent significant results.

**Abbreviations:** CI, confidence interval; OR, odds ratio.

[^1]: These authors contributed equally to this work
